Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 1
2004 2
2018 3
2019 2
2020 5
2021 2
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study.
Calabrese L, Cinotti E, D'Onghia M, Cartocci A, Rubegni P, Maccari F, Boulard C, Reguiai Z, Becherel PA, Jacobzone C, Begon E, Fite C, Walls B, Liegeon AL, Parier J, Chaby G, Perrot JL; Omcci Group. Calabrese L, et al. Among authors: jacobzone c. Acta Derm Venereol. 2025 Mar 12;105:adv42275. doi: 10.2340/actadv.v105.42275. Acta Derm Venereol. 2025. PMID: 40077977 Free article.
Tattoo complications in treated and non-treated psoriatic patients.
Grodner C, Beauchet A, Fougerousse AC, Quiles-Tsimaratos N, Perrot JL, Barthelemy H, Parier J, Maccari F, Beneton N, Bouilly-Auvray D, Ruer-Mulard M, Boulard C, Jacobzone C, Thomas-Beaulieu D, Pourchot D, Méry-Bossard L, Chaby G, Girard C, Duval-Modeste AB, Vermersch-Langlin A, Delaunay J, Marc S, Kemula M, Steff M, Bilan P, Liégeon AL, Aubert H, Solyga B, Kluger N, Mahé E; GEM Resopso. Grodner C, et al. Among authors: jacobzone c. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):888-896. doi: 10.1111/jdv.15975. Epub 2019 Oct 24. J Eur Acad Dermatol Venereol. 2020. PMID: 31568596
Building a scale for measuring burden of hand eczema: BoHEM.
Maccari F, Ezzedine K, Fougerousse AC, Mérhand S, Bordet C, Jacobzone C, Taieb C. Maccari F, et al. Among authors: jacobzone c. J Am Acad Dermatol. 2019 Jun;80(6):1784-1785. doi: 10.1016/j.jaad.2018.12.036. Epub 2018 Dec 23. J Am Acad Dermatol. 2019. PMID: 30586614 Free article. No abstract available.
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, Parier J, Maccari F, Perrot JL, Ruer-Mulard M, Bastien M, Begon E, Samimi M, Jacobzone C, Quiles-Tsimaratos N, Descamps V, Steff M, Bilan P, Vermersch-Langlin A, Kemula M, Amazan E, Kupfer-Bessaguet I, Cottencin AC, Prignano F, Livideanu B, Gottlieb J, Beauchet A, Mahé E; the Groupe d’Etudes Multicentriques (GEM) RESOPSO. Phan C, et al. Among authors: jacobzone c. Acta Derm Venereol. 2020 Nov 4;100(18):adv00316. doi: 10.2340/00015555-3678. Acta Derm Venereol. 2020. PMID: 33111960 Free PMC article.
Cladribine improves cutaneous manifestations, Dermatology Life Quality Index, and Mastocytosis Quality of Life of patients with mastocytosis.
Bugaut H, Maillard H, Jacobzone C, Haddad N, Le Pelletier F, Charlotte F, Arock M, Dubreuil P, Bulai Livideanu C, Hermine O, Barete S. Bugaut H, et al. Among authors: jacobzone c. J Am Acad Dermatol. 2024 May;90(5):1044-1046. doi: 10.1016/j.jaad.2023.12.056. Epub 2024 Jan 12. J Am Acad Dermatol. 2024. PMID: 38219804 No abstract available.
Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, Parier J, Maccari F, Chaby G, Bastien M, Begon E, Samimi M, Prignano F, Beauchet A, Mahé E; GEM Resopso. Phan C, et al. Drugs Aging. 2020 Sep;37(9):657-663. doi: 10.1007/s40266-020-00781-y. Drugs Aging. 2020. PMID: 32696432
Effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis under real-life conditions: a retrospective multicenter study.
Fougerousse AC, Ghislain PD, Reguiai Z, Maccari F, Parier J, Bouilly Auvray D, Chaby G, Pallure V, Schmutz JL, Clément C, Jacobzone C, Begon E, Esteve E; GEM ResoPso. Fougerousse AC, et al. Among authors: jacobzone c. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e644-e646. doi: 10.1111/jdv.16511. Epub 2020 May 25. J Eur Acad Dermatol Venereol. 2020. PMID: 32314452 No abstract available.
[Misdiagnosis of hidradenitis suppurativa continues to be a major issue. The R-ENS Verneuil study].
Loget J, Saint-Martin C, Guillem P, Kanagaratnam L, Becherel PA, Nassif A, Fougerousse AC, Siham M, Girard C, Barthelemy H, Chaby G, Gabison G, Perrot JL, Pallure V, Beneton N, Boye T, Jacobzone C, Begon E, Bernard P, Reguiai Z; sous l’égide de « ResoVerneil ». Loget J, et al. Among authors: jacobzone c. Ann Dermatol Venereol. 2018 May;145(5):331-338. doi: 10.1016/j.annder.2018.01.043. Epub 2018 Apr 26. Ann Dermatol Venereol. 2018. PMID: 29704958 French.
21 results